TGF-β Signaling Pathway-Based Model to Predict the Subtype and Prognosis of Head and Neck Squamous Cell Carcinoma

Background: Although immunotherapy with immune checkpoint therapy has been used to treat head and neck squamous cell carcinoma (HNSCC), response rates and treatment sensitivity remain limited. Recent studies have indicated that transforming growth factor-β (TGF-β) may be an important target for nove...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Lian, Guan, Zhenjie, Xue, Miaomiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108263/
https://www.ncbi.nlm.nih.gov/pubmed/35586572
http://dx.doi.org/10.3389/fgene.2022.862860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108263/
https://www.ncbi.nlm.nih.gov/pubmed/35586572
http://dx.doi.org/10.3389/fgene.2022.862860

Ejemplares similares